• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Eli Lilly & Co

+ Add to Watchlist


70.05 CHF 0.000.00%

As of 11:43:51 ET on 12/23/2014.

Snapshot for Eli Lilly & Co (LLY)

Open: 70.05 Day's Range: 70.05 - 70.05 Volume: 0
Previous Close: 70.05 52wk Range: 45.60 - 71.60 1-Yr Rtn: +57.32%

Stock Chart for LLY

No chart data available.
  • LLY:SW 70.05
  • 1M
  • 1Y
Interactive LLY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LLY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 25.5458
Relative P/E vs. SMI -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 2.7760
Est. PEG Ratio 2.6519
Market Cap (M CHF) 77,995.76
Shares Outstanding (M) 1,113.43
30 Day Average Volume 278
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.81%
Cash Dividend (USD) 0.5000
Dividend Ex-Date 02/11/2015
5 Year Dividend Growth -3.38%
Next Earnings Announcement 01/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LLY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LLY

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company's products are sold in countries around the world. Eli Lilly's products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.

John C LechleiterChairman/President/CEOMaria A CrowePres:Manufacturing Operations
Derica W RiceExec VP:Global Services/CFOJan M LundbergExec VP:Science/Pres:Research
More Company Profile & Key Executives for LLY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil